USPTO serial 79414298
REMPLIR - REDEFINING NERVE REPAIR
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 22, 2026
- Examiner
- BLAZICH, JOAN MICHELE
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with REMPLIR - REDEFINING NERVE REPAIR?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Matthew J. Stark
Matthew J. Stark Price Heneveld LLP3400 Innovation Court SEGrand Rapids, MI 49501United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Collagen for medical purposes; biodegradable implants for use in guided tissue regeneration, namely, living cells and implantable scaffolds comprising biological materials for use in human tissue regeneration and repair; surgical implants grown from stem cells being living tissue; therapeutic drugs and agents for use in tissue repair and regeneration; pharmaceutical and medical preparations for use in regeneration of damaged bone and soft tissue, including nerve tissue; surgical and medical dressings; biological preparations for medical purposes, namely, for use in tissue regeneration for tissue repair; biological preparations for medical use, namely, for use in tissue regeneration for tissue repair; dental implant materials being implantable scaffolds comprising biological materials including living cells and collagen; collagen bioinks in the nature of biological tissue cells intended for subsequent implantation for clinical purposes; collagen bioinks in the nature of biological tissues intended for subsequent implantation for clinical purposes; engineered human biological tissues being living cells and implantable scaffolds comprising biological materials for use in regenerative medicine; engineered animal biological tissues being living cells and implantable scaffolds comprising biological materials for use in regenerative medicine; biological implants comprised of human or animal connective tissues intended for subsequent implantation; biological implants, namely, living cells and implantable scaffolds comprising biological materials for use in human tissue regeneration and repair; biomaterials in the nature of biological tissue cells being living cells for medical purposes; biological tissue being living cells for implantation for use in tissue regeneration for tissue repair; engineered biological tissues being living cells for medical purposes; surgical implants comprising living tissue; surgical mesh comprised primarily of living tissue; biotechnological preparations for medical purposes, namely, living cells and implantable scaffolds comprising biological materials for use in human tissue regeneration and repair | ACTIVE | — |
| 010 | Artificial orthopaedic implants, namely, implants made from artificial biomaterials for use in the regeneration of bone and soft tissue, including nerve tissue; orthopaedic apparatus, namely, apparatus made from artificial biomaterials for use in the regeneration of bone and soft tissue, including nerve tissue; orthopaedic articles, namely, apparatus made from artificial biomaterials for use in the regeneration of bone and soft tissue, including nerve tissue; medical implants made from artificial materials; surgical implants comprised of artificial materials; surgical implants comprised of artificial materials for use in guided tissue regeneration; orthopaedic implants, namely, implants made from artificial biomaterials for use in the regeneration of bone and soft tissue, including nerve tissue; otological prostheses being prostheses consisting of artificial biomaterials; dental implants; implants being prostheses of artificial biomaterials, namely, bone prostheses and soft tissue prostheses for replacing bone and soft tissue for use in the body; implants being prostheses of artificial biomaterials, namely, bone prostheses for bone surgery; implants being prostheses of artificial biomaterials, namely, dental prostheses for dental surgery; implants being prostheses of artificial biomaterials, namely, bone prostheses for use in bone grafting; implants being prostheses of artificial biomaterials, namely, dental and bone prostheses for use in facial surgery; artificial surgical implants comprising artificial biomaterials; therapeutic articles for implantation, namely, surgical implants, made of artificial materials | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Orthocell Limited
- Other trademarks owned by Orthocell Limited
- Other trademarks owned by Orthocell Limited
- Other trademarks in Class 005
- Other trademarks in Class 010
- Similar marks named REMPLIR - REDEFINING NERVE REPAIR
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 22, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Sep 22, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 4, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 4, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 30, 2026 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jul 29, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 15, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 15, 2026 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jul 1, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 25, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jun 12, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 12, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 12, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 8, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 8, 2026 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Feb 5, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 16, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 16, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 10, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 9, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 8, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 2, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 8, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 7, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 7, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 9, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |